You are here

shingles

GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China

Fierce Pharma

Wed, 05/22/19 - 08:27 pm

Sales of shingles vaccine boost profits at GSK

Yahoo/Reuters

Wed, 02/6/19 - 09:44 am

GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'

Fierce Pharma

Tue, 12/11/18 - 10:16 am

Senators demand more from GlaxoSmithKline to boost Shingrix supply

Fierce Pharma

Fri, 07/6/18 - 10:15 am

GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand

Fierce Pharma

Thu, 06/21/18 - 10:56 pm

GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch

Fierce Pharma

Tue, 06/5/18 - 10:50 pm

GSK's Shingrix blows past sales projections, pushing 2018 estimates to $600M

Fierce Pharma

Mon, 04/30/18 - 07:36 pm

GlaxoSmithKline scores retail deal with CVS, spreading Shingrix to thousands of pharmacies

Fierce Pharma

Mon, 03/19/18 - 12:19 pm

Sorrento Therapeutics wins FDA nod for post-shingles pain patch

Drug Delivery Business News

Wed, 02/28/18 - 06:45 pm

Sorrento Therapeutics

post-shingles neuralgia

GSK's shingles vaccine gets green light from EMA panel

Reuters

Sun, 01/28/18 - 10:04 am

Vaccine approval buoys GSK new drug push

Biopharma Dive

Mon, 10/23/17 - 09:48 pm

GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine

Fierce Pharma

Sat, 10/21/17 - 10:30 am

GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix

Fierce Pharma

Tue, 10/17/17 - 08:24 pm

With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica

Fierce Pharma

Fri, 10/13/17 - 09:34 am

diabetic peripheral neuropathy

GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on

Endpoints

Thu, 09/14/17 - 09:54 am

Upcoming events – GSK’s shingles panel and Axovant takes on Alzheimer’s

EP Vantage

Sat, 08/26/17 - 07:46 pm

Alzheimer's disease

Merck’s Zostavax draws new litigation from patients alleging they contracted shingles

Fierce Pharma

Fri, 07/21/17 - 11:18 am

GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report

Fierce Pharma

Wed, 06/21/17 - 11:01 am

Zostavax patients sue Merck, claiming shingles shot caused injuries and death

Fierce Pharma

Tue, 03/14/17 - 04:38 pm

In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of Confirmed Herpes Zoster Cases by an Estimated 64 Percent in Immunocompromised Subjects

Yahoo

Sat, 02/25/17 - 02:00 pm

varicella zoster

Pages